Cosmo’s Headline About Cancer Survivor’s Weight Loss Is A Doozy
Like a cover on a book, headlines are supposed to entice potential readers ― but this Cosmopolitan one took that premise a little too far.
In a piece that went up on Cosmopolitan.com on Monday afternoon, editor Elizabeth Narins tells the story of 31-year-old Simone Harbinson and the life-threatening health scares she faced over the course of a tumultuous two years.
The story documents the sicknesses she endured and struggles she overcame, but the original headline, strangely, only focused on Harbinson’s weight loss:
Harbinson is an Instagram fitness blogger so we understand that exercise and healthy living is...
Source: Healthy Living - The Huffington Post - April 11, 2017 Category: Consumer Health News Source Type: news
FDA Approves Agent for Carcinoid Tumor –Related Diarrhea
The FDA has approved telotristat ethyl (Xermelo) tablets for the treatment of patients with carcinoid syndrome diarrhea that has not responded to somatostatin analogs alone. (Source: CancerNetwork)
Source: CancerNetwork - March 3, 2017 Category: Cancer & Oncology Authors: Ian Ingram Tags: Carcinoid Tumors Neuroendocrine Tumors News Source Type: news
Xermelo Approved for Tumor-Related Diarrhea
WEDNESDAY, March 1, 2017 -- Xermelo (telotristat ethyl) tablets have been approved by the U.S. Food and Drug Administration to treat adults with carcinoid syndrome diarrhea, one of a collection of symptoms related to rare carcinoid tumors.
Most of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 1, 2017 Category: Journals (General) Source Type: news
FDA approves Lexicon Pharma's carcinoid syndrome diarrhea drug
(Reuters) - The U.S. Food and Drug Administration said on Tuesday it had approved Lexicon Pharmaceuticals Inc's oral drug to treat carcinoid syndrome diarrhea, a condition that develops in patients with gastrointestinal tumors. (Source: Reuters: Health)
Source: Reuters: Health - February 28, 2017 Category: Consumer Health News Tags: healthNews Source Type: news
FDA Approves Xermelo (telotristat ethyl) as First and Only Oral Treatment for Carcinoid Syndrome Diarrhea in Cancer Patients with Metastatic Neuroendocrine Tumors
The Woodlands, Texas, February 28, 2017 – Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that the U.S. Food and Drug Administration (FDA) has approved Xermelo (telotristat ethyl) 250 mg as a first and only orally administered therapy... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - February 28, 2017 Category: Drugs & Pharmacology Source Type: news
Cabozantinib for Carcinoid and Pancreatic NETs:'Encouraging'Cabozantinib for Carcinoid and Pancreatic NETs:'Encouraging '
A phase 2 trial demonstrated that cabozantinib has promise in the treatment of advanced carcinoid and pancreatic neuroendocrine tumors.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 25, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Incidence of Pancreatic Carcinoid Tumors Rising in the U.S. Incidence of Pancreatic Carcinoid Tumors Rising in the U.S.
The incidence of primary pancreatic carcinoid tumors in the United States is increasing rapidly, new research shows.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 4, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Carcinoid Syndrome (Carcinoid Tumor)
Title: Carcinoid Syndrome (Carcinoid Tumor)Category: Diseases and ConditionsCreated: 5/9/2005 12:00:00 AMLast Editorial Review: 8/17/2016 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - August 17, 2016 Category: Nutrition Source Type: news
Answer revealed to this top-missed USMLE Step 2 question
Getting ready for the United States Medical Licensing Examination® (USMLE®) Step 2 is no easy feat, but we’re sharing expert insights to help give you a leg up. Take a look at the exclusive scoop on this month’s most-missed USMLE Step 2 test prep question. Think you have what it takes to rise above your peers? Test your USMLE knowledge, and view an expert video explanation of the answer from Kaplan Medical.
Once you’ve got this question under your belt, be sure to test your knowledge with other posts in this series.
Ready. Set. Go.
This month’s question that stumped most students:
A 42-year-old woman come...
Source: AMA Wire - May 25, 2016 Category: Journals (General) Authors: Troy Parks Source Type: news
How to Spot a Carcinoid Tumor Before It Spreads
Carcinoid tumors are rare, account for less than one percent of all colorectal cancers, and are very slow growing with a low likelihood of metastases. (Source: About.com Colon Cancer)
Source: About.com Colon Cancer - February 15, 2016 Category: Cancer & Oncology Authors: coloncancer.guide at about.com Tags: health Source Type: news
New Drug Shows Benefit in NET Carcinoid SyndromeNew Drug Shows Benefit in NET Carcinoid Syndrome
Telotristat etiprate is the first drug developed specifically for carcinoid syndrome, which occurs in patients with metastatic neuroendocrine tumors (NETs). Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 6, 2015 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Carcinoid Heart DiseaseCarcinoid Heart Disease
Learn about the pathology, diagnosis, and treatment of carcinoid tumors. Oncology Nursing Forum (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 29, 2015 Category: Consumer Health News Tags: Nursing Journal Article Source Type: news
So how can non-smokers like the BBC's Nick Robinson get lung cancer?
Lisa Pigram, 42, who lives in Essex had a bronchial carcinoid tumour. It was the same condition the BBC's political editor Nick Robinson had. (Source: the Mail online | Health)
Source: the Mail online | Health - March 3, 2015 Category: Consumer Health News Source Type: news
Nick Robinson's cancer: 'Timing lousy, prognosis good'
As BBC's political editor reveals he has a rare lung tumour, Ruth Wood assesses the treatment options (Source: Telegraph Health)
Source: Telegraph Health - March 2, 2015 Category: Consumer Health News Tags: nick robinson cancer tumour carcinoid tumour bbc cancer symptoms Source Type: news
Unprecedented Responses Seen in Neuroendocrine TumorsUnprecedented Responses Seen in Neuroendocrine Tumors
A novel chemotherapy combination demonstrated efficacy in a wide variety of tumor types, including difficult-to-treat carcinoid tumors. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 15, 2014 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
